International Psychogeriatrics
Follow the Journal on Twitter
Read all our published articles!
International Psychogeriatrics is the official journal of the International Psychogeriatric Association. It is a multidisciplinary, peer-reviewed journal for researchers, clinicians, and educators in the field of psychogeriatrics. The journal emphasis is on an integrated and broadly encompassing approach to older people, which considers physical and mental health and illness, as well as psychosocial factors and societal perspectives. During the past four years, the journal has increased its frequency from bimonthly to monthly; the 2023 impact factor is 4.6.
The Editor-in-Chief invites submission of original research articles, literature reviews, case reports and letters to the editor. Editorials and book reviews are commissioned directly by the Editor-in-Chief. All articles must be original material, not previously published in English and not currently under consideration for publication elsewhere.
International Psychogeriatrics is published twelve times per year. The journal often receives grants and support for special focused supplement issues.
Instructions for contributors, copies of all published issues as well as some forthcoming articles and additional information about the journal can be found at our website via Elsevier:
https://www.intpsychogeriatrics.org/
EDITOR-IN-CHIEF
Dilip V. Jeste, M.D.
Senior Associate Dean for Healthy Aging and Senior Care
Estelle and Edgar Levi Chair in Aging
Distinguished Professor of Psychiatry and Neurosciences Director
Sam and Rose Stein Institute for Research on Aging
University of California, San Diego
San Diego, California 92093 US
Deputy Editors
Alastair Flint
University Health Network | Canada
Orestes Forlenza
University of São Paulo | Brazil
Latha Velayudhan
King's College London Institute of Psychiatry Psychology & Neuroscience | United Kingdom
Statistical Editor
Stephan Arndt, Ph.D.
The University of Iowa | United States of America
Editorial Board Members
George S. Alexopoulos
Weill Cornell Medicine, United States of America
Liat Ayalon, Ph.D.
Bar-Ilan University, Israel
Helen Chiu
The Chinese University of Hong Kong, Hong Kong
Yeates Conwell
University of Rochester Medical Center, United States of America
Byron Creese, Ph.D.
Brunel University London College of Health Medicine and Life Sciences, United Kingdom
Migita D'Cruz
National Institute of Mental Health and Neurosciences, India
Devangere Devanand
New York State Psychiatric Institute, United States of America
David Facal Mayo, Ph.D.
University of Santiago de Compostela, Spain
Corinne Fischer
University of Toronto, Canada
Brent Forester
Tufts University, United States of America
Mary Ganguli, M.D., M.P.H., F.R.C.P. C.
University of Pittsburgh School of Medicine, United States of America
Maria Paula Gastiazoro, Ph.D.
CONICET Santa Fe, Argentina
Marie Anne Gebara, M.D.
University of Pittsburgh, United States of America
Debby Gerritsen
Radboud University Nijmegen Medical Centre, Netherlands
Clarissa Giebel
University of Liverpool, United Kingdom
Mustafa M. Husain
The University of Texas Southwestern Medical Center, United States of America
Gabriel Ivbijaro
NHS Wood Street Health Centre, United Kingdom
Dylan Jester
VA Palo Alto Health Care System, United States of America
Preethy Kathiresan, M.D., D.M.
National Centre for Ageing (NCA), AIIMS, India
Dimitris Kiosses
Weill Cornell Medicine, United States of America
Rob Kok
Parnassia Psych-Medical Centre, Netherlands
Helen Lavretsky, M.D.
University of California Los Angeles David Geffen School of Medicine, United States of America
Susan W. Lehmann, M.D.
The Johns Hopkins University School of Medicine, United States of America
Tomás León, M.D.
Memory and Neuropsychiatry Clinic, Chile
Iracema Leroi
Global Brain Health Institute, United States of America
Heather Leutwyler
University of California San Francisco, United States of America
Raimundo Mateos
University of Santiago de Compostela, Spain
Benoit Mulsant
University of Toronto,Canada
Cynthia Munro
The Johns Hopkins University School of Medicine,United States of America
Déborah Oliveira, Ph.D.
Andrés Bello University, Chile
Ana Luisa Sosa Ortiz, Ph.D.
National Institute of Neurology and Neurosurgery Manuel Velasco Suarez, Mexico
Carmelle Peisah, M.B.B.S., M.D., F.R.A.N.Z.C.P.
University of New South Wales, Australia
Perminder Sachdev, A.M., M.B.B.S., M.D., F.R.A.N.Z.C.P., Ph.D., F.A.H.M.S.
University of New South Wales,Australia
Yuto Satake
The University of Osaka Graduate School of Medicine, Faculty of Medicine, Japan
Fei Sun
Michigan State University, United States of America
Rajesh Tampi
Cleveland Clinic Foundation, United States of America
Olga Theou, Ph.D.
Dalhousie University, Canada
Huali Wang, M.D., Ph.D.
Peking University Sixth Hospital, China
MANAGING EDITOR
Jen Kowalski
IPA Executive Director
Email: jkowalski@ipa-online.org
PAST EDITORS
Nicola T. Lautenschlager
David Ames
Manfred Bergener
Gene Cohen
Robin Eastwood
Sanford Finkel
Kazuo Hasegawa
Akira Homma
Costs, Discounts, and Waivers for Open Access Articles
IPA Members will always receive a discount as a benefit of membership! Additional waivers and discounts are also available – see below:
As an open access journal, articles accepted for publication in International Psychogeriatrics will require payment of an “article publishing charge” (APC). During submission, authors are presented with a personalized APC rate based on their individual context (i.e., country, institutional affiliation, funding, and/or IPA membership).
- IPA Member Discount
- 20% discount off the APC: $2800 (full-length articles) and $1760 (short articles) ($3500 and $2200, respectively, for non-Members)
- Payment is made after acceptance
- Letters and invited pieces are free
- Institution and University Consortia Funding Agreements
- Elsevier has funding agreements with institutions and university consortia worldwide. Eligible authors will not need to pay the APC -- it will be funded or subsidized by these groups.
- See: https://www.elsevier.com/open-access/agreements
- Funding Body Agreements
- Elsevier has agreements with funding bodies worldwide that provide research grants to eligible authors and will cover most or all APCs (e.g., WHO, World Bank, Wellcome, United Nations University).
- See: https://www.elsevier.com/open-access/funding-arrangements
- Research4Life waivers
- Waivers of the entire APC or discounts of 50% (depending on the World Bank classification) will be provided to authors affiliated with institutions conducting research in the Resarch4Life developing countries participating in the program.
- See: https://www.research4life.org/access/eligibility for more information.
- Elsevier’s Waiving Policy: Waivers may be granted should an author from a non-Research4Life country be unable to afford the APC and can demonstrate an absence of research funding.
